C. Azen

1.3k total citations
36 papers, 1.1k citations indexed

About

C. Azen is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology. According to data from OpenAlex, C. Azen has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Biochemistry, 15 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in C. Azen's work include Metabolism and Genetic Disorders (21 papers), Diet and metabolism studies (13 papers) and Folate and B Vitamins Research (9 papers). C. Azen is often cited by papers focused on Metabolism and Genetic Disorders (21 papers), Diet and metabolism studies (13 papers) and Folate and B Vitamins Research (9 papers). C. Azen collaborates with scholars based in United States, Canada and Germany. C. Azen's co-authors include Richard Koch, Eva Friedman, Bobbye Rouse, Malcolm L. Williamson, Felix de la Cruz, Reuben Matalon, Will Hanley, Harvey L. Levy, Marvin D. Nelson and D.W. Jacobsen and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and The Journal of Pediatrics.

In The Last Decade

C. Azen

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Azen United States 19 688 427 407 245 193 36 1.1k
Guido Anello Italy 17 86 0.1× 208 0.5× 83 0.2× 532 2.2× 198 1.0× 27 838
Ingeborg Krieger United States 19 166 0.2× 143 0.3× 111 0.3× 34 0.1× 78 0.4× 40 683
Christoph Gasteyger Switzerland 16 96 0.1× 104 0.2× 378 0.9× 35 0.1× 55 0.3× 29 1.0k
Ekaterina Koledova Germany 15 100 0.1× 173 0.4× 100 0.2× 39 0.2× 281 1.5× 52 763
Paolo Cavarzere Italy 15 42 0.1× 165 0.4× 129 0.3× 65 0.3× 113 0.6× 66 638
Mehmet Keskın Türkiye 13 52 0.1× 118 0.3× 164 0.4× 31 0.1× 130 0.7× 52 697
O Søvik Norway 17 94 0.1× 277 0.6× 101 0.2× 36 0.1× 113 0.6× 58 1.1k
Anna Noczyńska Poland 16 62 0.1× 141 0.3× 113 0.3× 26 0.1× 52 0.3× 84 818
Bruno Schisano Italy 14 33 0.0× 288 0.7× 196 0.5× 66 0.3× 22 0.1× 15 1.1k
Ciril Kržišnik Slovenia 15 40 0.1× 192 0.4× 98 0.2× 20 0.1× 89 0.5× 38 681

Countries citing papers authored by C. Azen

Since Specialization
Citations

This map shows the geographic impact of C. Azen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Azen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Azen more than expected).

Fields of papers citing papers by C. Azen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Azen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Azen. The network helps show where C. Azen may publish in the future.

Co-authorship network of co-authors of C. Azen

This figure shows the co-authorship network connecting the top 25 collaborators of C. Azen. A scholar is included among the top collaborators of C. Azen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Azen. C. Azen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Olney, Robert C., et al.. (2011). Plasma C‐type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease. Clinical Endocrinology. 76(2). 228–235. 6 indexed citations
3.
Miller, D. Craig, Yasir Qazi, Miroslaw Smogorzewski, et al.. (2009). Foxp3 Staining in BK Virus Allograft Nephropathy and Comparison With Acute Cellular Rejection. Transplantation Proceedings. 41(10). 4188–4192. 7 indexed citations
4.
Brumm, Virdette L., et al.. (2004). Neuropsychological outcome of subjects participating in the PKU Adult Collaborative Study: A preliminary review. Journal of Inherited Metabolic Disease. 27(5). 549–566. 94 indexed citations
5.
Hoffman, Jill A., Kenneth I. Weinberg, C. Azen, et al.. (2004). Human leukocyte antigen‐DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients. Transplant Infectious Disease. 6(4). 147–155. 27 indexed citations
6.
Koch, Richard, Will Hanley, Harvey L. Levy, et al.. (2000). Maternal Phenylketonuria: An International Study. Molecular Genetics and Metabolism. 71(1-2). 233–239. 39 indexed citations
7.
Waisbren, Susan E., Pi‐Nian Chang, Harvey L. Levy, et al.. (1998). Neonatal neurological assessment of offspring in maternal phenylketonuria. Journal of Inherited Metabolic Disease. 21(1). 39–48. 17 indexed citations
8.
Azen, C., et al.. (1998). Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels. European Journal of Clinical Nutrition. 52(8). 582–587. 55 indexed citations
9.
Friedman, Eva, Richard Koch, C. Azen, et al.. (1996). The international collaborative study on maternal phenylketonuria: organization, study design and description of the sample. European Journal of Pediatrics. 155(S1). S158–S161. 15 indexed citations
10.
Koch, Richard, et al.. (1996). Care of the adult with phenylketonuria. European Journal of Pediatrics. 155(S1). S90–S92. 25 indexed citations
11.
Hanley, Will, Richard Koch, Harvey L. Levy, et al.. (1996). The North American Maternal Phenylketonuria Collaborative Study, developmental assessment of the offspring: preliminary report. European Journal of Pediatrics. 155(S1). S169–S172. 13 indexed citations
12.
Azen, C., et al.. (1996). Summary of findings from the United States Collaborative Study of children treated for phenylketonuria. European Journal of Pediatrics. 155(S1). S29–S32. 38 indexed citations
13.
Koch, Richard, Reuben Matalon, Bobbye Rouse, et al.. (1994). The international collaborative study of maternal phenylketonuria: status report 1994. Acta Paediatrica. 83(s407). 111–119. 46 indexed citations
14.
Koch, Richard, Harvey L. Levy, Reuben Matalon, et al.. (1993). The North American collaborative study of maternal phenylketonuria (PKU). 8(1). 89–96. 19 indexed citations
15.
Azen, C., et al.. (1993). Maternal tobacco use and substance abuse: reported prevalence rates and associations with the delivery of small for gestational age neonates.. PubMed. 81(3). 396–401. 27 indexed citations
16.
Koch, Richard, Will Hanley, Harvey L. Levy, et al.. (1990). A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada. Journal of Inherited Metabolic Disease. 13(4). 641–650. 35 indexed citations
17.
Rouse, Bobbye, Lyle Lockhart, Reuben Matalon, et al.. (1990). Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations. Journal of Inherited Metabolic Disease. 13(3). 289–291. 38 indexed citations
18.
Fishler, K, C. Azen, Eva Friedman, & Richard Koch. (1989). School achievement in treated PKU children. Journal of Intellectual Disability Research. 33(6). 493–498. 14 indexed citations
19.
Koch, Richard, C. Azen, Nancy Hurst, Eva Friedman, & K Fishler. (1987). The effects of diet discontinuation in children with phenylketonuria. European Journal of Pediatrics. 146(1). A12–A16. 32 indexed citations
20.
Koch, Richard, C. Azen, Eva Friedman, & Malcolm L. Williamson. (1983). Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age. Journal of Inherited Metabolic Disease. 7(2). 86–90. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026